Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
Navigating Emerging Biomarkers in MS Care
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Precision Medicine for Myasthenia Gravis
Discharge Planning After Myasthenic Crisis
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Exploring Genetic Links Between EBV Clearance and MS Risk
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
New Therapies, New Strategy: Rethinking MG Inpatient Care
A Closer Look at the Biology Behind MS Progression
Outcome Measures Capture Progression in Late-Onset TK2d
More Than a Myopathy: The Lived Experience of TK2d
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.